Implementation and Effectiveness of an Interprofessional Support Program for Patients with Type 2 Diabetes in Swiss Primary Care: A Study Protocol

Bawab, Noura; Moullin, Joanna C.; Perraudin, Clémence; Bugnon, Olivier

doi:10.3390/pharmacy8020106

Cited by 3 publications

(3 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The intervention, called Siscare, is an interprofessional patient support program that includes (1) regular motivational semistructured interviews (patient–community pharmacist), at least every 3 months; (2) electronic monitoring of medication adherence by electronic pillbox (MEMS and MEMS AS, AARDEX Group, Switzerland) and patient-reported and clinical outcomes; and (3) interactions between the referent physician and the pharmacist to promote the continuity of care. 23 The referent physician of the patient is a general practitioner or a specialist, who is usually responsible for coordinating the patient's diabetes care. The interaction between the health care professionals begins with the transmission of a report from the pharmacist to the physician after each interview, including a description of medication adherence, barriers and facilitators, adverse reactions, clinical outcomes, and patient engagement.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Building Interprofessional Collaborative Practices Through a Support Program for Patients With Type 2 Diabetes in Primary Care

Bawab

Moullin

Jotterand

et al. 2023

J Contin Educ Health Prof

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

“…21,22 The objective of this study was to assess the building of interprofessional collaborative practices throughout the implementation process of a support program (Siscare) for patients with T2D, Siscare-DT2, in primary care in the French-speaking part of Switzerland. 23…”

mentioning

confidence: 99%

Building Interprofessional Collaborative Practices Through a Support Program for Patients With Type 2 Diabetes in Primary Care

Bawab

Moullin

Jotterand

et al. 2023

J Contin Educ Health Prof

Self Cite

View full text Add to dashboard Cite

show abstract

“…This research is part of a larger study that used a hybrid implementation-effectiveness design based on data from a prospective, multicenter, observational study (13). This article focuses on the effectiveness results.…”

Section: Methodsmentioning

confidence: 99%

Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes

Bawab¹,

Schneider²,

Ballabeni³

et al. 2022

Preprint

View full text Add to dashboard Cite

Objective. To assess the effectiveness of an interprofessional support program (Siscare) that includes motivational interviews (patient-pharmacist), electronic monitoring (EM of medications, patient-reported and clinical outcomes monitoring, and interactions with physicians for patients with type 2 diabetes in French-speaking Switzerland. Methods. This was a prospective, multicenter, observational cohort study using a hybrid implementation-effectiveness design. Individual daily adherence to at least one oral antidiabetic medication was measured by EM. A global adherence score was estimated by the product of a model-estimated implementation and a nonparametric estimate of persistence over time. Clinical outcomes (A1C, blood glucose, BMI, blood pressure, heart rate, and cholesterol levels) and quality of life QoL were analyzed over time using linear mixed-effect models. Results. A total of 212 patients were included from 27 pharmacies; 120 patients (57%) were followed up for at least 15 months. In total, 140 patients (66%) were male, the mean age was 64 ± 11 years, and the mean number of chronic medications per patient at baseline was 5 ± 3. Of 178 patients who used EM, 95% (95% CI 92–99%) remained persistent at the end of the follow-up period. The percentage of persistent patients taking their medications appropriately (implementation) was stable during follow-up and was estimated to be 90% (95% CI 87–92%) at baseline and 88% (95% CI: 84–91%) at month 15. At baseline, the mean A1C and BMI were 7.5% and 31 kg/m2, respectively, which decreased by 0.5% (P = 0.012) and 0.6 kg/m2 (P = 0.017), respectively, after 15 months. QoL remained stable during follow-up. Conclusion. The program supports medication adherence and improves clinical outcomes, illustrating the overall preventive effect of coordinated care.

show abstract

Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes

et al. 2022

View full text Add to dashboard Cite

OBJECTIVE To assess the effectiveness of an interprofessional support program (Siscare) that includes motivational interviews (patient-pharmacist), electronic monitoring (EM) of medications, patient-reported and clinical outcomes monitoring, and interactions with physicians for patients with type 2 diabetes in French-speaking Switzerland. METHODS This was a prospective, multicenter, observational cohort study using a hybrid implementation-effectiveness design. Individual daily adherence to at least one oral antidiabetic medication was measured by EM. A global adherence score was estimated by the product of a model-estimated implementation and a nonparametric estimate of persistence over time. Clinical outcomes (A1C, blood glucose, BMI, blood pressure, heart rate, and cholesterol levels) and quality of life (QoL) were analyzed over time using linear mixed-effect models. RESULTS A total of 212 patients were included from 27 pharmacies; 120 patients (57%) were followed up for at least 15 months. In total, 140 patients (66%) were male, the mean age was 64 ± 11 years, and the mean number of chronic medications per patient at baseline was 5 ± 3. Of 178 patients who used EM, 95% (95% CI 92–99%) remained persistent at the end of the follow-up period. The percentage of persistent patients taking their medications appropriately (implementation) was stable during follow-up and was estimated to be 90% (95% CI 87–92%) at baseline and 88% (95% CI: 84–91%) at month 15. At baseline, the mean A1C and BMI were 7.5% and 31 kg/m2, respectively, which decreased by 0.5% (P = 0.012) and 0.6 kg/m2 (P = 0.017), respectively, after 15 months. QoL remained stable during follow-up. CONCLUSION The program supports medication adherence and improves clinical outcomes, illustrating the overall preventive effect of coordinated care.

show abstract

Implementation and Effectiveness of an Interprofessional Support Program for Patients with Type 2 Diabetes in Swiss Primary Care: A Study Protocol

Cited by 3 publications

References 44 publications

Building Interprofessional Collaborative Practices Through a Support Program for Patients With Type 2 Diabetes in Primary Care

Building Interprofessional Collaborative Practices Through a Support Program for Patients With Type 2 Diabetes in Primary Care

Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes

Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes

Contact Info

Product

Resources

About